A Win For Kezar Life Sciences, Inc.
Tue, Jun 28, 2022 at 08:33 PM
Kezar Life Sciences, Inc. (KZR:NASDAQ) rocketted at $8.29, a gain of 43.4%. On Tue, Jun 28, 2022, KZR:NASDAQ hit a New 2-Week High of $8.29. The stock got featured on our News Catalysts scanner on Tue, Jun 28, 2022 at 12:42 PM in the 'BIOTECH' category. From Tue, Jun 14, 2022, the stock recorded 77.78% Up Days and 80.00% Green Days
The stock spiked on Tue, Jun 28, 2022 at $11.02 with a volume of 48M+.
About Kezar Life Sciences, Inc. (KZR:NASDAQ)
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
Top 10 Gainers:
- Agile Therapeutics, Inc. (AGRX:NASDAQ), 89.76%
- Endo International plc (ENDP:NASDAQ), 85.33%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 52.17%
- Tuniu Corporation (TOUR:NASDAQ), 46.01%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Kezar Life Sciences, Inc. (KZR:NASDAQ), 43.43%
- InflaRx N.V. (IFRX:NASDAQ), 40.74%
- EzFill Holdings Inc. (EZFL:NASDAQ), 35.59%
- Graybug Vision Inc. (GRAY:NASDAQ), 35.38%
- Motorsport Games Inc. (MSGM:NASDAQ), 29.63%